Yes I think not only is it enough to get to Phase III I think it's enough to get fast track designation from the FDA.
The monotherapy used Phenoxodiol alone injected only twice a week into very very sick women (only months too live). The fact that it had any effect at all is a major breakthrough.
The success rate will only get better from here, here's why:
1) They are yet to perfect the dosage and treatment regime. The current study is using 4 different dosages (over a big range).
2) Phenoxodiol when used with Cisplatin is over 20 times more potent than when used alone. This trial will commence shortly.
3) Phenoxodiol derivatives (Phenoxodiol molecules clumped together) are much more active than Phenoxodiol alone. NV5063 is 500% more active than Phenoxodiol.
4) Clinical trials on earlier stage cancer patients e.g. the cervical cancer trial should see a better response.
Hope this helps.
Cheers, Munch.
I hold.
NRT Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
